Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial

The National Lung Screening Trial (NLST) randomized high-risk current and former smokers to three annual screens with either low-dose computed tomography (LDCT) or chest radiography (CXR) and demonstrated a significant reduction in lung cancer mortality in the LDCT arm after a median of 6.5 years�...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of thoracic oncology 2019-10, Vol.14 (10), p.1732-1742
Main Authors:	The National Lung Screening Trial Research Team, National Lung Screening Trial Research Team
Format:	Article
Language:	English
Subjects:	Adenocarcinoma of Lung - diagnosis Adenocarcinoma of Lung - epidemiology Adenocarcinoma of Lung - mortality Adenocarcinoma of Lung - therapy Aged Carcinoma, Large Cell - diagnosis Carcinoma, Large Cell - epidemiology Carcinoma, Large Cell - mortality Carcinoma, Large Cell - therapy Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - epidemiology Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - therapy Carcinoma, Squamous Cell - diagnosis Carcinoma, Squamous Cell - epidemiology Carcinoma, Squamous Cell - mortality Carcinoma, Squamous Cell - therapy Early Detection of Cancer - methods Female Follow-Up Studies Humans Incidence Low-dose CT Lung cancer Lung Neoplasms - diagnosis Lung Neoplasms - epidemiology Lung Neoplasms - mortality Lung Neoplasms - therapy Male Middle Aged Mortality Prognosis Screening Small Cell Lung Carcinoma - diagnosis Small Cell Lung Carcinoma - epidemiology Small Cell Lung Carcinoma - mortality Small Cell Lung Carcinoma - therapy Survival Rate United States - epidemiology
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!